Dolutegravir and lamivudine and tenofovir only product in oral dose form
|
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)
Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
Id1197400002
StatusDefined
Has manufactured dose formOral tablet
Has unit of presentationTablet
Has BoSSLamivudine
Has precise active ingredientLamivudine
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSTenofovir disoproxil
Has precise active ingredientTenofovir disoproxil fumarate
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSDolutegravir
Has precise active ingredientDolutegravir sodium
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Global Patient Set